Ribometrix Announces Lead Program Target and Presentation of Preclinical Data at the International Congress of the Society for Melanoma Research
DURHAM, N.C.--(BUSINESS WIRE)--Nov 6, 2023--<a ...
DURHAM, N.C.--(BUSINESS WIRE)--Nov 6, 2023--<a ...
PARIS--(BUSINESS WIRE)--Nov 6, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 3, 2023--Ankyra Therapeutics, an emerging clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced data from a preclinical study using ANK-101, an IL-12 anchored therapeutic, in combination with cytotoxic ...
CHICAGO--(BUSINESS WIRE)--Nov 3, 2023--Tempus, a leader in artificial intelligence and precision medicine, today announced <a ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--Nov 3, 2023--On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by <a ...
DUBLIN--(BUSINESS WIRE)--Nov 3, 2023--The <a ...